ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank57
3Y CAGR-16.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-16.7%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.33M | -69.5% |
| 2024 | $7.62M | -19.6% |
| 2023 | $9.47M | +135.8% |
| 2022 | $4.02M | +5559.2% |
| 2021 | $71000.00 | +103.9% |
| 2020 | $-1.84M | -6961.5% |
| 2019 | $-26000.00 | -1200.0% |
| 2018 | $-2000.00 | - |